Fischbach W, Malfertheiner P, Hoffmann J C, Bolten W, Bornschein J, Götze O, Höhne W, Kist M, Koletzko S, Labenz J, Layer P, Miehlke St, Morgner A, Peitz U, Preiss J, Prinz C, Rosien U, Schmidt W, Schwarzer A, Suerbaum St, Timmer A, Treiber G, Vieth M
Medizinische Klinik II, Klinikum Aschaffenburg.
Z Gastroenterol. 2009 Dec;47(12):1230-63. doi: 10.1055/s-0028-1109855. Epub 2009 Dec 3.
This guideline updates a prior consensus recommendation of the German Society for Digestive and Metabolic Diseases (DGVS) from 1996. It was developed by an interdisciplinary cooperation with representatives of the German Society for Hygiene and Microbiology, the Society for Pediatric Gastroenterology and Nutrition (GPGE), and the German Society for Rheumatology. The guideline is methodologically based on recommendations of the Association of the Scientific Medical Societies in Germany (AWMF) for providing a systematic evidence-based S 3 level consensus guideline and has also implemented grading criteria according to the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) process. Clinical applicability of study results as well as specifics for Germany in terms of epidemiology, antibiotic resistance status, diagnostics, and therapy were taken into account.
本指南更新了德国消化和代谢疾病学会(DGVS)1996年的先前共识建议。它是通过与德国卫生与微生物学会、儿科胃肠病学和营养学会(GPGE)以及德国风湿病学会的代表进行跨学科合作制定的。该指南在方法上基于德国科学医学学会协会(AWMF)提供系统性循证S3级共识指南的建议,并且还根据GRADE(推荐评估、制定和评价分级)流程实施了分级标准。研究结果的临床适用性以及德国在流行病学、抗生素耐药状况、诊断和治疗方面的具体情况均已考虑在内。